LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion into Houston Neurogene Inc. recently expanded its facilities to Houston, Texas, where they constructed a state-of-the-art gene therapy manufacturing facility. This expansion presents an opportunity for sales professionals to engage with the company and offer relevant services or products to support their growing operations.

Strategic Partnerships Neurogene Inc. has engaged in strategic partnerships, such as the recent merger with Neoleukin Therapeutics, Inc. and collaboration with the University of Rochester. These partnerships indicate a willingness to collaborate and innovate, providing a window for sales development representatives to explore synergies and propose mutually beneficial solutions.

Innovative Product Launches With the launch of NGN-401 for Rett syndrome, Neurogene Inc. has demonstrated a commitment to developing cutting-edge genetic medicines to address complex neurological diseases. Sales professionals can capitalize on this by showcasing products or services that align with Neurogene's innovative approach and cater to their specific therapeutic focus.

Financial Stability Neurogene Inc. boasts a solid financial standing with revenues ranging between $10M - 50M and a total funding of $184M. This financial stability provides a strong foundation for potential sales engagements, as the company may be more inclined to invest in new solutions or collaborations that can further enhance their offerings and market presence.

Talent Acquisition The recruitment of key personnel like Julie Jordan as Chief Medical Officer and Donna Cochener as Senior Vice President, General Counsel, signifies Neurogene Inc.'s focus on building a high-caliber team to drive its mission forward. Sales development representatives can leverage these new appointments as an opportunity to establish connections and tailor offerings that align with the company's leadership priorities and objectives.

Similar companies to Neurogene Inc.

Neurogene Inc. Tech Stack

Neurogene Inc. uses 8 technology products and services including Facebook Pixel, SAS, SAP, and more. Explore Neurogene Inc.'s tech stack below.

  • Facebook Pixel
    Analytics
  • SAS
    Business Intelligence
  • SAP
    Customer Relationship Management
  • MySQL
    Database
  • NetSuite
    E-commerce
  • jQuery
    Javascript Libraries
  • Ubuntu
    Operating Systems
  • Justworks
    Payroll Management And Benefits Administration

Media & News

Neurogene Inc.'s Email Address Formats

Neurogene Inc. uses at least 1 format(s):
Neurogene Inc. Email FormatsExamplePercentage
First.Last@neurogene.comJohn.Doe@neurogene.com
96%
FirstMiddle.Last@neurogene.comJohnMichael.Doe@neurogene.com
1%
Last.First@neurogene.comDoe.John@neurogene.com
2%
First.Middle@neurogene.comJohn.Michael@neurogene.com
1%

Frequently Asked Questions

Where is Neurogene Inc.'s headquarters located?

Minus sign iconPlus sign icon
Neurogene Inc.'s main headquarters is located at 535 W 24th St 5th Floor New York, New York 10011 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Neurogene Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Neurogene Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neurogene Inc.'s stock symbol?

Minus sign iconPlus sign icon
Neurogene Inc. is a publicly traded company; the company's stock symbol is NGNE.

What is Neurogene Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Neurogene Inc.'s official website is neurogene.com and has social profiles on LinkedIn.

How much revenue does Neurogene Inc. generate?

Minus sign iconPlus sign icon
As of August 2024, Neurogene Inc.'s annual revenue reached $35M.

What is Neurogene Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Neurogene Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neurogene Inc. have currently?

Minus sign iconPlus sign icon
As of August 2024, Neurogene Inc. has approximately 98 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: J. C. J.Chief Scientific Officer: S. C.Chief Medical Officer: E. A.. Explore Neurogene Inc.'s employee directory with LeadIQ.

What industry does Neurogene Inc. belong to?

Minus sign iconPlus sign icon
Neurogene Inc. operates in the Biotechnology Research industry.

What technology does Neurogene Inc. use?

Minus sign iconPlus sign icon
Neurogene Inc.'s tech stack includes Facebook PixelSASSAPMySQLNetSuitejQueryUbuntuJustworks.

What is Neurogene Inc.'s email format?

Minus sign iconPlus sign icon
Neurogene Inc.'s email format typically follows the pattern of . Find more Neurogene Inc. email formats with LeadIQ.

How much funding has Neurogene Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2024, Neurogene Inc. has raised $184M in funding. The last funding round occurred on Dec 16, 2020 for $115M.

When was Neurogene Inc. founded?

Minus sign iconPlus sign icon
Neurogene Inc. was founded in 2018.
Neurogene Inc.

Neurogene Inc.

Biotechnology ResearchNew York, United States51-200 Employees

Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies.

Although the human genome was sequenced for the first time nearly 20 years ago, the true genomics revolution is taking place now, providing us with the ability to radically alter rare, genetic disorders. At Neurogene, we are working to provide medicines to improve the lives of neurologically-impaired and developmentally-delayed children and their families.

We are building a team of passionate, driven individuals who envision a world in which all families have access to genetic medicines, even if the disorder is exceedingly rare. 

To learn more, please visit http://www.neurogene.com/careers/.

Section iconCompany Overview

Headquarters
535 W 24th St 5th Floor New York, New York 10011 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NGNE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $184M

    Neurogene Inc. has raised a total of $184M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2020 in the amount of $115Mas a series B.

  • $10M$50M

    Neurogene Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $184M

    Neurogene Inc. has raised a total of $184M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2020 in the amount of $115Mas a series B.

  • $10M$50M

    Neurogene Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.